Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide in Refractory Crohn's Disease and Ulcerative Colitis
NCT00720538Phase 3Completed
- Sponsor
- IRCCS Burlo Garofolo
- Start
- Aug 2008
- Primary completion
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of thalidomide in Crohn's disease, ulcerative colitis (UC), sponsored by IRCCS Burlo Garofolo. Started Aug 2008; status: completed.
02
Drugs
thalidomide
03
Conditions
Crohn's diseaseulcerative colitis (UC)
Beyond the preview
Go deeper on NCT00720538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00720538.